Notably, the proportion of extensively differentiating CD45.1+ cells (>7 division, CD44+ CD62L−) increased in the lymph node and spleen, irrespective of tumor presence (Fig. 2h–j and Supplementary Fig. 4c–j). Here, CD44 is linked to neoplasm.